Latest News for: qilu
Edit
Gettysburg Times
02 Jun 2026
Minghui Pharmaceutical and Qilu Pharmaceutical Co-Announces Updated Clinical Data of MHB088C (QLC5508) from Phase I/II ...
HANGZHOU and SHANGHAI, China, June 1, 2026 /PRNewswire/ -- ...
Edit
Minghui Pharmaceutical and Qilu Pharmaceutical Co-Announces Updated Clinical Data of MHB088C (QLC5508) from Phase I/II study in Heavily Pretreated mCRPC Patients at 2026 ASCO Annual Meeting
PR Newswire 01 Jun 2026
Under an exclusive licensing and collaboration agreement, Qilu Pharmaceutical holds rights for the development, manufacturing, and commercialization of MHB088C in Greater China ... In Greater China, Qilu ...
- 1